{"id":8647,"date":"2016-10-18T11:00:52","date_gmt":"2016-10-18T11:00:52","guid":{"rendered":"http:\/\/admin.acceleratingscience.com\/biobanking\/?p=8647"},"modified":"2016-10-18T11:00:52","modified_gmt":"2016-10-18T11:00:52","slug":"biobank-legacy-planning-preparing-for-the-worst-case","status":"publish","type":"post","link":"https:\/\/www.thermofisher.com\/blog\/biobanking\/biobank-legacy-planning-preparing-for-the-worst-case\/","title":{"rendered":"Biobank Legacy Planning: Preparing for the Worst Case"},"content":{"rendered":"

\"MotherLegacy planning is an essential step in establishing and maintaining a biobank, given the time and expense involved as well as the responsibility to use donors’ precious resources appropriately. Legacy planning involves preparing for circumstances that may result in biobank closure or significant operational changes. Matzke et al. (2016) describe some of the fundamental considerations for preparing and executing a legacy plan.1<\/sup><\/p>\n

In the United Kingdom, membership in the National Cancer Research Institute’s Confederation of Cancer Biobanks requires biobanks and institutions to sign a memorandum of understanding and agree to alignment with a common set of guiding principles, which include maintaining continuity. Operationally, a biobank needs to consider funding stewardship and the costs associated with closure and redistribution of its contents. Other considerations include making sure that biospecimen information remains up-to-date and accurate<\/span>, which ultimately aids in estimating biospecimen transfer costs.<\/p>\n

The authors suggest that, prior to formulating a plan for any biospecimen transfer, it is vital to assess the current state of a collection. This should include a review of the biobank to verify the elements of the collection, such as the following:<\/p>\n